56 related articles for article (PubMed ID: 2045935)
1. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.
Leskinen-Kallio S; Ruotsalainen U; Någren K; Teräs M; Joensuu H
J Nucl Med; 1991 Jun; 32(6):1211-8. PubMed ID: 2045935
[TBL] [Abstract][Full Text] [Related]
2. [S-methyl-
Narushima K; Nishii R; Okazumi S; Shimada H; Akutsu Y; Maeda T; Yasuda S; Yamada S; Shuto K; Tamura K; Yamazaki K; Shinoto M; Ishikawa H; Mori M; Matsubara H
Sci Rep; 2022 Aug; 12(1):13694. PubMed ID: 35953702
[TBL] [Abstract][Full Text] [Related]
3. Comparison of ten predictive equations for estimating lean body mass with dual-energy X-ray absorptiometry in older patients.
Puri T; Blake GM
Br J Radiol; 2022 May; 95(1133):20210378. PubMed ID: 35143259
[TBL] [Abstract][Full Text] [Related]
4.
Kim M; Higuchi T; Nakajima T; Andriana P; Hirasawa H; Tokue A; Kurihara J; Yokoo S; Tsushima Y
Oral Radiol; 2019 Sep; 35(3):308-314. PubMed ID: 30778900
[TBL] [Abstract][Full Text] [Related]
5. Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging.
Nishii R; Higashi T; Kagawa S; Arimoto M; Kishibe Y; Takahashi M; Yamada S; Saiki M; Arakawa Y; Yamauchi H; Okuyama C; Hojo M; Munemitsu T; Sawada M; Kobayashi M; Kawai K; Nagamachi S; Hirai T; Miyamoto S
Contrast Media Mol Imaging; 2018; 2018():1292746. PubMed ID: 30026674
[TBL] [Abstract][Full Text] [Related]
6. From Carbon-11-Labeled Amino Acids to Peptides in Positron Emission Tomography: the Synthesis and Clinical Application.
Pekošak A; Filp U; Poot AJ; Windhorst AD
Mol Imaging Biol; 2018 Aug; 20(4):510-532. PubMed ID: 29411226
[TBL] [Abstract][Full Text] [Related]
7. FDG PET-CT in follicular lymphoma: a case-based evidence review.
Smith SD; Redman M; Dunleavy K
Blood; 2015 Feb; 125(7):1078-82. PubMed ID: 25527711
[No Abstract] [Full Text] [Related]
8. Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma.
Nguyen XC; Lee WW; Amin AM; Eo JS; Bang SM; Lee JS; Kim SE
Nucl Med Mol Imaging; 2010 Apr; 44(1):39-44. PubMed ID: 24899936
[TBL] [Abstract][Full Text] [Related]
9. Methodology for quantitative rapid multi-tracer PET tumor characterizations.
Kadrmas DJ; Hoffman JM
Theranostics; 2013 Oct; 3(10):757-73. PubMed ID: 24312149
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of radiolabeled methionine in hepatocellular carcinoma.
Kuang Y; Wang F; Corn DJ; Tian H; Lee Z
Mol Imaging Biol; 2014 Feb; 16(1):44-52. PubMed ID: 23921714
[TBL] [Abstract][Full Text] [Related]
11. Managing lymphoma with non-FDG radiotracers: current clinical and preclinical applications.
Kong FL; Ford RJ; Yang DJ
Biomed Res Int; 2013; 2013():626910. PubMed ID: 23841079
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic usefulness of an amino acid tracer, α-[N-methyl-(11)C]-methylaminoisobutyric acid ( (11)C-MeAIB), in the PET diagnosis of chest malignancies.
Nishii R; Higashi T; Kagawa S; Kishibe Y; Takahashi M; Yamauchi H; Motoyama H; Kawakami K; Nakaoku T; Nohara J; Okamura M; Watanabe T; Nakatani K; Nagamachi S; Tamura S; Kawai K; Kobayashi M
Ann Nucl Med; 2013 Nov; 27(9):808-21. PubMed ID: 23824782
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of software-based image fusion of computed tomography and F18-FDG PET scans in patients with malignant lymphoma.
Henninger B; Putzer D; Kendler D; Uprimny C; Virgolini I; Gunsilius E; Bale R
ScientificWorldJournal; 2012; 2012():821694. PubMed ID: 22654631
[TBL] [Abstract][Full Text] [Related]
14. A case of central nervous system lymphomatoid granulomatosis; characteristics of PET imaging and pathological findings.
Nishihara H; Nakasato M; Sawa H; Murakami H; Yamamoto D; Moriyama K; Kato N; Hashimoto I; Kamada H; Tanaka S
J Neurooncol; 2009 Jun; 93(2):275-8. PubMed ID: 19104755
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the diagnosis and therapy of Richter's syndrome.
Swords R; Bruzzi J; Giles F
Med Oncol; 2007; 24(1):17-32. PubMed ID: 17673808
[TBL] [Abstract][Full Text] [Related]
16. PET in lymphoma.
Collins CD
Cancer Imaging; 2006 Oct; 6(Spec No A):S63-70. PubMed ID: 17114080
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells.
Stöber B; Tanase U; Herz M; Seidl C; Schwaiger M; Senekowitsch-Schmidtke R
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):932-9. PubMed ID: 16604346
[TBL] [Abstract][Full Text] [Related]
18. Limitations of PET for imaging lymphoma.
Barrington SF; O'Doherty MJ
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S117-27. PubMed ID: 12748831
[TBL] [Abstract][Full Text] [Related]
19. PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma.
Schiepers C; Filmont JE; Czernin J
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S82-8. PubMed ID: 12719922
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
